| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |